Replies to post #215822 on Anavex Life Sciences Corp (AVXL)

[tradeherpete]

Thus BIIB stuff smells very bad. A drug that had a trail cancelled is now going for approval... Really!

Biogen is throwing up smoke to misdirect attention as they did at AAIC summer 2018 with the same hooey. It was Ban 2401 then that they were going for BTD.
Quote:
Eisai and Biogen will move forward with late-stage clinical trials and are working with regulatory agencies in the United States, Japan, and Europe to discuss the results, design additional trials, and gain expedited review as a breakthrough therapy for Alzheimer disease.

How’s that coming? Not soon or very soon I expect, more like never.

https://www.neurologylive.com/conferences/aaic-2018/ban2401-removes-brain-amyloid-possibly-slows-cognitive-decline-in-alzheimer-disease

imo